Chest Pain is Common but Actual Severity is Rare
UCSF Study Finds that Most Visits to ER for Chest Pain are Not Life -Threatening
Chest pain is one of the most common reasons to visit the emergency room, but a new UC San Francisco study shows that only a fraction of all cases actually lead to a diagnosis of a life-threatening condition.
As a result, the researchers suggest that significant diagnostic testing may not be warranted in a general population where the overall risk is low.
The study will be published June 13, 2016, in JAMA Internal Medicine.
The research involved a probability analysis that examined emergency department visits in the United States by adults over a seven-year span where the chief concern was non-traumatic chest pain. It found that only 5.5 percent of those visits led to serious diagnoses, such as heart attacks.
Chest pain is the second most frequent cause of emergency department visits among adults, amounting to more than 8 million visits annually nationwide.
“Because chest pain is a characteristic of several life-threatening conditions and the risks of missing these diagnoses are high, clinicians may overestimate the probability of these conditions,” said lead author, Renee Hsia, MD, MSc, a professor of emergency medicine and health policy at UCSF.
“As a result, it’s important to establish accurate pre-test probabilities and determine the need for further testing, in addition to findings from physical examinations, laboratory results, and other testing.”
The study analyzed 10,907 patient records, which represented 42 million patient visits to an emergency department with a primary symptom of chest pain. The analysis included all ER visits from Jan. 1, 2005, to Dec. 31, 2011, for adults 18 years and older.
Data were taken from the National Hospital Ambulatory Medical Care Survey, a national probability sample of visits to nonfederal, general acute-care U.S. hospitals conducted by the National Center for Health Statistics.
In the analysis, nearly 53 percent of the patients were female and 75 percent were between the ages of 18 and 64. Approximately 64 percent were white, 21.5 percent were black and nearly 11 percent were Hispanic. A huge portion of the patients (84.4 percent) were treated in an urban area, and were covered by private insurance (45.1 percent), while Medicare or Medicaid paid the costs of approximately 32 percent of the other patients.
The most common diagnosis was nonspecific chest pain (51.7 percent). When stratified by age group, the prevalence of serious diagnoses increased with age.
Diagnoses related to chest pain that are traditionally taught to medical students as life-threatening conditions include acute coronary syndrome, aortic dissection, pulmonary embolism, esophageal rupture, and perforated peptic ulcer. The researchers found that when examining each of these conditions independently, 5.1 percent were for acute coronary syndrome, and all the rest totaled less than 0.4 percent of cases.
The findings suggest that “significant diagnostic testing to rule out these diagnoses may not be warranted in a general population of undifferentiated patients,” the authors wrote. They concluded that as health care cost pressures mount, improving diagnostic accuracy is increasingly important to limit wasteful tests and improve patient outcomes.
Co-authors are Zachariah Hale, a medical student at the UCSF School of Medicine; and Jeffrey Tabas, MD, a professor of emergency medicine at UCSF.
UC San Francisco (UCSF) is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. It includes top-ranked graduate schools of dentistry, medicine, nursing and pharmacy; a graduate division with nationally renowned programs in basic, biomedical, translational and population sciences; and a preeminent biomedical research enterprise. It also includes UCSF Health, which comprises top-ranked hospitals, UCSF Medical Center and UCSF Benioff Children’s Hospitals in San Francisco and Oakland – and other partner and affiliated hospitals and healthcare providers throughout the Bay Area.